rs142939330
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS1
The ENST00000374695.8(HSPG2):c.10280G>A(p.Arg3427Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000529 in 1,575,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3427W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000374695.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPG2 | NM_005529.7 | c.10280G>A | p.Arg3427Gln | missense_variant | 75/97 | ENST00000374695.8 | NP_005520.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPG2 | ENST00000374695.8 | c.10280G>A | p.Arg3427Gln | missense_variant | 75/97 | 1 | NM_005529.7 | ENSP00000363827 | P1 | |
HSPG2 | ENST00000374676.4 | c.183-1240G>A | intron_variant | 3 | ENSP00000363808 | |||||
HSPG2 | ENST00000471322.2 | n.41G>A | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00122 AC: 185AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000901 AC: 168AN: 186500Hom.: 0 AF XY: 0.000793 AC XY: 79AN XY: 99660
GnomAD4 exome AF: 0.000457 AC: 650AN: 1423186Hom.: 0 Cov.: 32 AF XY: 0.000446 AC XY: 314AN XY: 704314
GnomAD4 genome AF: 0.00121 AC: 184AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.00115 AC XY: 86AN XY: 74464
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 16, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | HSPG2: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 08, 2022 | The HSPG2 c.10280G>A; p.Arg3427Gln variant (rs142939330), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 295739). This variant is found in the African population with an allele frequency of 0.21% (42/19,592 alleles) in the Genome Aggregation Database. The arginine at codon 3427 is weakly conserved, and computational analyses predict that this variant is neutral (REVEL: 0.021). Due to limited information, the clinical significance of the p.Arg3427Gln variant is uncertain at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2018 | - - |
Lethal Kniest-like syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Schwartz-Jampel syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 30, 2020 | - - |
HSPG2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 10, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at